Co-Delivery of Docetaxel and Salinomycin to Target Both Breast Cancer Cells and Stem Cells by PLGA/TPGS Nanoparticles
Jie Gao,1,2,* Junjie Liu,1,3,* Fangyuan Xie,4,* Ying Lu,3 Chuan Yin,5 Xian Shen1 1Department of Gastrointestinal Surgery, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Zhejiang, People’s Republic of China; 2Scientific Research Center...
Main Authors: | Gao J, Liu J, Xie F, Lu Y, Yin C, Shen X |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-11-01
|
Series: | International Journal of Nanomedicine |
Subjects: | |
Online Access: | https://www.dovepress.com/co-delivery-of-docetaxel-and-salinomycin-to-target-both-breast-cancer--peer-reviewed-article-IJN |
Similar Items
-
Combined delivery of salinomycin and docetaxel by dual-targeting gelatinase nanoparticles effectively inhibits cervical cancer cells and cancer stem cells
by: Qin Wang, et al.
Published: (2021-01-01) -
Oral Delivery of DMAB-Modified Docetaxel-Loaded PLGA-TPGS Nanoparticles for Cancer Chemotherapy
by: Zeng Xiaowei, et al.
Published: (2011-01-01) -
Development of an immunochromatography assay for salinomycin and methyl salinomycin in honey
by: Xiaoxin Xu, et al.
Published: (2019-01-01) -
Combined using of paclitaxel and salinomycin active targeting nanostructured lipid carriers against non-small cell lung cancer and cancer stem cells
by: Jianwen Zhou, et al.
Published: (2019-01-01) -
Polymer–lipid hybrid anti-HER2 nanoparticles for targeted salinomycin delivery to HER2-positive breast cancer stem cells and cancer cells
by: Li J, et al.
Published: (2017-09-01)